Zweig Di Menna Associates LLC Natera, Inc. Transaction History
Zweig Di Menna Associates LLC
- $1.04 Billion
- Q3 2025
A detailed history of Zweig Di Menna Associates LLC transactions in Natera, Inc. stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 132,500 shares of NTRA stock, worth $27.1 Million. This represents 2.05% of its overall portfolio holdings.
Number of Shares
132,500
Previous 124,100
6.77%
Holding current value
$27.1 Million
Previous $21 Million
1.73%
% of portfolio
2.05%
Previous 2.54%
Shares
6 transactions
Others Institutions Holding NTRA
# of Institutions
751Shares Held
127MCall Options Held
1.13MPut Options Held
449K-
Vanguard Group Inc Valley Forge, PA12.4MShares$2.53 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.9MShares$2.44 Billion0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY11.6MShares$2.38 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.38 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.25MShares$869 Million2.96% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $19.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...